Musculoskeletal Clinical Regulatory Advisers

Musculoskeletal Clinical Regulatory Advisers (MCRA), now an IQVIA business, is a premier integrated CRO and consulting firm for the medical technology sector. Founded in 2004 and headquartered in Washington, D.C., it provides end-to-end services encompassing regulatory strategy, clinical trials, reimbursement, quality assurance, and market access. The firm leverages deep therapeutic specialization across areas like orthopedics, cardiovascular, neurology, and digital health to accelerate client product development and commercialization globally. Its acquisition by IQVIA positions it within a larger healthcare intelligence network, enhancing its scale and data capabilities.

Integrated service platform combining regulatory strategy, clinical research operations, reimbursement & market access (RHEMA), quality assurance, healthcare compliance, and distribution logistics, enhanced by specialized AI & Imaging Center and cybersecurity services. Leverages IQVIA's data analytics and global infrastructure.

MCRA competes with large, full-service CROs (e.g., ICON, PPD) that have device divisions, as well as niche regulatory and reimbursement consulting firms. Its differentiated position stems from deep, exclusive MedTech focus and fully integrated service model. Acquisition by IQVIA provides significant scale and data advantage over smaller pure-play competitors.